Thank you for your participation!
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115
About the Conference
The First Stop for Growing Your
The 15th Annual Trans-Pacific Health Sciences Dialogue is a meeting for biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2016 Trans-Pacific Health Sciences Dialogue!
Industry News from FiercePharmaAsia
- Sanofi to refund Philippines for $28M worth of unused Dengvaxia dosesFacing growing demand from officials and lawmakers, Sanofi Pasteur agreed to refund the Philippine government for unused Dengvaxia doses worth about 1.4 billion Philippine pesos ($28 million). But safety questions continue to swirl after preliminary autopsy results came out from children who died after receiving Dengvaxia, though no causal link has been proven.
- Philippines suspends Dengvaxia approval, fines Sanofi a symbolic $2,000With all the commotion and fury from different directions targeting Sanofi’s Dengvaxia, the Philippines has now only suspended the vaccine’s approval and fined the drugmaker a symbolic $2,000.
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.